Wang Y, Yamaguchi K, Shimada Y, Zhao X, Miyagi T
Division of Biochemistry, Research Institute, Miyagi Prefectural Cancer Center, Natori, Miyagi, Japan.
Eur J Biochem. 2001 Apr;268(8):2201-8. doi: 10.1046/j.1432-1327.2001.02069.x.
Unlike microbial sialidases, mammalian sialidases possess strict substrate specificity, for example the human membrane-associated sialidase, which hydrolyzes only gangliosides. To cast light on the molecular basis of this narrow substrate preference, predicted active site amino-acid residues of the human membrane sialidase were altered by site-directed mutagenesis. When compared with the active site amino-acid residues proposed for Salmonella typhimurium sialidase, only five out of 13 residues were found to be different to the human enzyme, these being located upstream of the putative transmembrane region. Alteration of seven residues, including these five, was followed by transient expression of the mutant enzymes in COS-1 cells and characterization of their kinetic properties using various substrates. Substitution of glutamic acid (at position 51) by aspartic acid and of arginine (at position 114) by glutamine or alanine resulted in retention of good catalytic efficiency toward ganglioside substrates, whereas other substitutions caused a marked reduction. The mutant enzyme E51D exhibited an increase in hydrolytic activity towards GM2 as well as sialyllactose (which are poor substrates for the wild-type) with change to a lower Km and a higher Vmax. R114Q demonstrated a substrate specificity shift in the same direction as E51D, whereas R114A enhanced the preference for gangliosides GD3 and GD1a that are effectively hydrolyzed by the wild-type. The inhibition experiments using 2-deoxy-2,3-didehydro-N-acetylneuraminic acid were consistent with the results in the alteration of substrate specificity. The findings suggest that putative active-site residues of the human membrane sialidase contribute to its substrate specificity.
与微生物唾液酸酶不同,哺乳动物唾液酸酶具有严格的底物特异性,例如人类膜相关唾液酸酶,它仅水解神经节苷脂。为了阐明这种狭窄底物偏好的分子基础,通过定点诱变改变了人类膜唾液酸酶预测的活性位点氨基酸残基。与鼠伤寒沙门氏菌唾液酸酶提出的活性位点氨基酸残基相比,发现13个残基中只有5个与人类酶不同,这些残基位于假定跨膜区域的上游。包括这5个残基在内的7个残基发生改变后,在COS-1细胞中瞬时表达突变酶,并使用各种底物对其动力学性质进行表征。将谷氨酸(第51位)替换为天冬氨酸,将精氨酸(第114位)替换为谷氨酰胺或丙氨酸,导致对神经节苷脂底物保持良好的催化效率,而其他替换则导致显著降低。突变酶E51D对GM2以及唾液乳糖(野生型的不良底物)的水解活性增加,同时Km降低,Vmax升高。R114Q表现出与E51D相同方向的底物特异性转变,而R114A增强了对野生型有效水解的神经节苷脂GD3和GD1a的偏好。使用2-脱氧-2,3-二脱氢-N-乙酰神经氨酸的抑制实验与底物特异性改变的结果一致。这些发现表明,人类膜唾液酸酶的假定活性位点残基有助于其底物特异性。